Palantir Lifts Sales Forecast as AI Boom Fuels Record Growth
Palantir Technologies raises its 2025 sales outlook to $4.4 billion after strong Q3 results and surging demand for its AI-powered data analytics from governments and businesses.
            Palantir Technologies raises its 2025 sales outlook to $4.4 billion after strong Q3 results and surging demand for its AI-powered data analytics from governments and businesses.
            
        IAC signs an AI content licensing deal with Microsoft’s Copilot after a challenging Q3 2025. People Inc. drives digital growth as the media giant seeks stability amid industry disruption.
        Hims & Hers Health rose in after-hours trading after revealing talks with Novo Nordisk about offering Wegovy’s new obesity pill. The telehealth firm also beat Q3 revenue estimates, reporting nearly $600 million in sales and strong subscriber growth.
        The US Department of Justice is investigating Regencell Bioscience’s extreme stock volatility after its shares skyrocketed 46,000%, prompting questions over trading activity.